News
Alcon's Future Looks Fruitful as New Innovation and Commercial Execution Spark Market Outperformance
During a surgical process, doctors need many handpiece consumables ... and technical support for these machines. Alcon has the top market position in phacoemulsification (70% in the US and 50% ...
For instance, Alcon significantly boosted its R&D ... Additionally, disposable surgical instruments, such as single-use phacoemulsification handpieces, saw a 20% higher adoption rate in 2024 ...
GENEVA, Switzerland & ORLANDO, Fla., March 24, 2025--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and LENSAR ...
Eye care giant Alcon appears to have gained the upper hand in the ongoing power struggle with Aurion Biotech by securing a majority stake in the clinical-stage company and replacing its CEO.
Alcon, a leader in eye care, has shown solid performance since its 2019 spin-off, with strong growth prospects and strategic acquisitions enhancing its long-term outlook. The company reported ...
Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon’s cataract equipment and technology portfolio Next generation technology will be expanded globally, improving the efficiency of ...
Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive, in the culmination of a months-long struggle for control.
Small, crowded eyes tend to make phacoemulsification challenging. Short axial length coupled with a crowded anterior chamber angle and increased vitreous pressure is a surgeon’s nightmare.
Multinational eye care major Alcon is preparing to roll out multiple products in India over the coming months, in response to growing demand for advanced ophthalmic technologies and a strategic ...
Leverages Alcon’s global scale with Aurion’s cell therapy expertise to accelerate U.S. Phase 3 development in fall of 2025 Aurion’s lead asset received Breakthrough Therapy Designation and ...
In patients with posterior capsule rupture, 60% of cases occurred during the stage of phacoemulsification. The timing of rupture is likely affected by the presence of anterior capsule tears.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results